Literature DB >> 750825

The effect of elaidic acid incorporation upon the lipid composition of Ehrlich Ascites tumor cells and of the host's liver.

A B Awad.   

Abstract

The incorporation of elaidic acid into Ehrlich ascites tumor cells (EATC) upon feeding the host an elaidic acid-rich diet has been investigated in the present study. The EATC lipids contained only one-half the concentration of elaidic acid found in the lipids of either the host livers or of livers from normal mice. On the other hand, elaidic acid incorporation into tumor cells was close to that of ascites fluid. This incorporation was mainly into phospholipids; the highest into choline phospholipids and ethanolamine phospholipids. Some changes in the EATC fatty acid composition were noted due to this incorporation. EATC phospholipids had reduced polyunsaturated fatty acids as compared with oleic acid-grown cells. The same was true with respect to ascites fluid phospholipids, but neutral lipids were not altered. Tumor development was accompanied by an increase in elaidic acid of the host's liver. Elaidic acid incorporation into tumor cells resulted in a reduction in the amount of all major lipids in the tumor. In contrast, elaidic acid had no effect on lipid composition of livers from normal mice and and-tumor bearing mice, and also had no effect upon the lipids of the ascites fluid that bathes the tumor cells. The incorporation of elaidic acid into the lipids of EATC, normal liver and host liver did not affect the relative composition of phospholipids in these tissues. The development of the tumor did result in decreases in triacylglycerols and esterified cholesterol, and increases in phospholipids and free cholesterol in the livers of host animals.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 750825     DOI: 10.1007/bf02533839

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  43 in total

1.  EFFECTS OF ALLOXAN DIABETES AND ADRENALINE ON CONCENTRATIONS OF FREE FATTY ACIDS IN RAT HEART AND DIAPHRAGM MUSCLES.

Authors:  P B GARLAND; P J RANDLE
Journal:  Nature       Date:  1963-07-27       Impact factor: 49.962

2.  The effect of alterations in fatty acid composition and cholesterol content on the nonelectrolyte permeability of Acholeplasma laidlawii B cells and derived liposomes.

Authors:  R N Mcelhaney; J de Gier; E C van der Neut-Kok
Journal:  Biochim Biophys Acta       Date:  1973-03-16

3.  Lipid composition of selected margarines.

Authors:  D L Carpenter; H T Slover
Journal:  J Am Oil Chem Soc       Date:  1973-09       Impact factor: 1.849

4.  Modification of the Lowry procedure for the analysis of proteolipid protein.

Authors:  M B Lees; S Paxman
Journal:  Anal Biochem       Date:  1972-05       Impact factor: 3.365

5.  [Comparative metabolism of C-14 elaidic and oleic acids in rats. II. Distribution, turnover and desaturation].

Authors:  N Munsch; M Pascaud
Journal:  Bull Soc Chim Biol (Paris)       Date:  1969

6.  Hepatoma, host liver, and normal rat liver phospholipids as affected by diet.

Authors:  R Wood
Journal:  Lipids       Date:  1975-12       Impact factor: 1.880

7.  Inhibition of in vitro cholesterol synthesis by fatty acids.

Authors:  M Kuroda; A Endo
Journal:  Biochim Biophys Acta       Date:  1976-01-18

8.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

9.  Effect of essential fatty acid deficiency on the lipid composition of the Yoshida ascites hepatoma (AH 130) and of the liver and blood plasma from host and normal rats.

Authors:  S Ruggieri; A Fallani; D Tombaccini
Journal:  J Lipid Res       Date:  1976-09       Impact factor: 5.922

10.  Studies on long chain cis- and trans-acyl-CoA esters and Acyl-CoA dehydrogenase from rat heart mitochondria.

Authors:  G O Korsrud; H B Conacher; G A Jarvis; J L Beare-Rogers
Journal:  Lipids       Date:  1977-02       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.